LY43578
LY43578 is an orally active aromatase inhibitor. LY43578 inhibits P-450-dependent p-nitroanisole O-demethylation and ethylmorphine N-demethylation in hepatic microsomes isolated from rat, with the IC50 of 0.3 and 5 μΜ, respectively. LY43578 can be used for neurological disorder study[1][2].
Product Specifications
CAS Number
26766-35-8
UNSPSC
12352005
Target
Cytochrome P450; Monoamine Oxidase
Type
Reference compound
Related Pathways
Metabolic Enzyme/Protease; Neuronal Signaling
Applications
Neuroscience-Neuromodulation
Field of Research
Cardiovascular Disease
Assay Protocol
https://www.medchemexpress.com/ly43578.html
Purity
99.76
Solubility
DMSO : 100 mg/mL (ultrasonic)
Smiles
OC(C1=CC=C(C=C1)Cl)(C2=CN=CN=C2)C3=CC=C(C=C3)Cl
Molecular Formula
C17H12Cl2N2O
Molecular Weight
331.20
References & Citations
[1]Lindstrom TD, et al. Disposition of the aromatase inhibitor LY56110 and associated induction and inhibition studies in rats, dogs, and monkeys. Fundam Appl Toxicol. 1987;8 (4) :595-604.|[2]Gonzalez MI, et al. Injection of an aromatase inhibitor after the critical period of sexual differentiation. Pharmacol Biochem Behav. 1994;47 (1) :183-186.
Shipping Conditions
Room Temperature
Storage Conditions
-20°C, 3 years; 4°C, 2 years (Powder)
Scientific Category
Reference compound1
Clinical Information
No Development Reported
Available Sizes
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog
LY434154 100 µg
Nck (NCK1) (NM_001190796) Human Over-expression Lysate
Sign In for Pricing
View Details 
BNC042160-500 1x 500 µL
CD86 (Dendritic Cells Maturation Marker) (C86/2160R), CF405S conjugate, 0.1mg/mL
Sign In for Pricing
View Details 
